Private, clinician-led weight loss support designed around your goals, lifestyle and pace.

The body naturally tries to hold onto weight, it is designed to protect you from hunger and energy loss

When you cut calories, hunger hormones like ghrelin rise and metabolism slows, making it harder to keep weight off.

Medical options such as Wegovy® and Mounjaro® work with your body’s biology to help regulate appetite and support lasting progress alongside lifestyle changes and clinical care.
Start with a quick BMI check. It takes a moment. You will see where you are today and what a healthy range looks like. And if you want support, we’re here for that too.

Enter your weight & height to get an indication of where your BMI stands.
Your eligibility is assessed by our clinicians based on your BMI, medical history, current medications and previous treatment experience.
| Criteria | Typical Guidance |
|---|---|
| BMI 30+ | Usually eligible |
| BMI 27+ with health conditions | Often eligible |
| Existing medications |

.png&w=1116&q=75)
Small daily habits make a big difference.
Our clinicians listen, guide, and help you make confident choices about your health at your pace.
Every assessment is private, judgment-free, and reviewed by a qualified prescriber.
| Reviewed by clinician |
| Previous GLP-1 use | Assessed individually |
This helps build trust, set clear expectations and reduce drop-off.
Have a concern or experiencing side effects? Send us a message. We will keep things simple, use clear language, and check in after you start.

Answer a few questions at your own pace. A UK clinician will review your answers, and if treatment’s right for you, we will handle the prescription and discreet delivery.

Unmarked packaging, low-key updates, and your details kept safe. No waiting rooms, no awkward chats, just care on your terms.

Have a concern or experiencing side effects? Send us a message. We will keep things simple, use clear language, and check in after you start.
15 Products
-1.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£216.80
-2.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£98.00

Mounjaro is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity for the treatment of type 2 diabetes and for weight management, including weight loss and weight maintenance, in eligible adults.Once-weekly pre-filled injection pen for use in the abdomen, thigh, or upper armWorks by activating both GLP-1 and GIP receptors to help regulate appetite and blood sugar levelsTreatment usually starts at 2.5 mg once weekly and may be increased gradually under clinical supervision up to a maximum of 15 mgSuitable for adults with BMI 30+ or BMI 27+ with weight-related health conditions, subject to clinician assessmentContinued treatment requires regular medical review and dose adjustmentNot suitable for anyone under 18Prescription supplied only following approval by a licensed clinicianSAFETY INFORMATION
£173.24
-3.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£117.81
-4.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£167.30
-5.png&w=1440&q=75)
Wegovy is a prescription-only once-weekly injection used alongside a reduced-calorie diet and increased physical activity to support weight loss and weight maintenance in eligible adults with obesity or overweight with weight-related health conditions.Once-weekly prefilled pen for injection under the skin of the abdomen, thigh or upper armTreatment starts at 0.25 mg once weekly, increasing gradually over 16 weeks to a maintenance dose, under clinician supervisionUse on the same day each week. Missed dose guidance appliesSuitable for adults with BMI 30+ or BMI 27+ or above with weight-related health conditions, subject to clinical assessmentContinued treatment requires regular medical review and evidence of clinical benefitSAFETY INFORMATION
£123.74
Filter